Welcome: Guest | Register | Login |

Aarden Pharmaceuticals Inc

Profile last edited on: 2/18/2019
351 West 10th Street Suite 505
Indianapolis, IN 46202
  (317) 690-2453
Business Identifier: Drugs targeting phosphatase family of proteins: emphasis on protein tyrosine phosphatases
Public Profile:
Aarden is a small molecule drug discovery and development company. The company's novel technology from the labs of the Indiana University School of Medicine is a chemistry breakthrough that will enable it to make drugs against a previously undruggable set of intracellular phosphatase (PTP) disease targets. Aarden Pharmaceuticals, Inc. develops drugs targeting the phosphatase family of proteins with emphasis on protein tyrosine phosphatases that catalyze the removal of phosphate groups from tyrosine residues of proteins and play key roles along with the tyrosine kinases in various signal transduction pathways. The companys drug programs focus on infectious diseases, cancer, metabolic, and autoimmune therapeutic areas. Record seems to suggest firm ceased operation in/around 2013

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Inhibitors of Mycobacterial Protein Tyrosine Phosphatase B (Mptpb) for Therapy Of

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920